Products

CoolBiz®

AI-native

Next-generation conversational AI, compliant by architecture.

coolbiz.ai Customer Service & Success / AI Support Agents

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Joseph Burruss
@coolbizinc· 1 followers
Launched
2mo ago
2026-09-14 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events2 marketing moves

Marketing moves

Launches, search & content, referrals, promotions
X accounts@coolbizinc

  • Launched on Product HuntLaunch

    Compliance-First AI Operations Platform

    Sep 14 · 2mo agoLaunch page

    At the time: <5K visits/mo1 concurrent move

  • Launched on LaunchIgniterLaunch

    CoolBiz® — Compliance-First AI Operations Platform

    Sep 14 · 2mo agoLaunch page

    At the time: <5K visits/mo1 concurrent move

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2024-12-12

KeywordMonthly volume
translate44.6M
claude ai17.3M
translate to spanish209.9K
coolbiz30
coolbiz ai30

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-09-14

Key pages

Weekly snapshots
coolbiz.ai/ Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does CoolBiz® get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is CoolBiz® and what platforms does it support?
CoolBiz® is catalogued under AI Support Agents: Next-generation conversational AI, compliant by architecture.. Supported platforms: Web.

Related products in this category

Customer Service & Success / AI Support Agents

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.